Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2002 Jun;46(6):2014–2016. doi: 10.1128/AAC.46.6.2014-2016.2002

Detection of a Variant Metallo-β-Lactamase, IMP-10, from Two Unrelated Strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans Strain

Shizuko Iyobe 1,*, Haruko Kusadokoro 2, Ayako Takahashi 3, Sachie Yomoda 3, Toyoji Okubo 1, Akio Nakamura 4, Koji O'Hara 4
PMCID: PMC127220  PMID: 12019129

Abstract

The gene blaIMP-10 of a variant metallo-β-lactamase, IMP-10, had a single base replacement of G by T at nucleotide 145, which led to an amino acid alteration of Val49 to Phe compared to the IMP-1 enzyme, indicating that IMP-10 was a point mutation derivative of IMP-1. Highly purified enzymes revealed that IMP-10 was different from IMP-1 in its extremely low hydrolyzing activities for penicillins, such as benzylpenicillin, ampicillin, and piperacillin.


The metallo-β-lactamase IMP-1, which belongs to molecular class B (2), is clinically important because of its broad substrate specificity and its efficient hydrolysis of almost all of the β-lactam antibiotics, such as cephems, penicillins, and especially carbapenems (15). Since the IMP-1-encoding gene, blaIMP-1, was cloned and sequenced, blaIMP-1 or blaIMP-1-like genes have been detected with imipenem-resistant bacteria of clinical origin by the PCR method with primers constructed for the blaIMP-1 sequence (12, 19). Furthermore, sequence analysis of the blaIMP-1-like genes has so far discerned nine kinds of variant IMP-type β-lactamases (3, 6, 8, 17, 23, 24) (GenBank accession numbers AF290912, AF318077, AY033653, and AB074436). Among IMP-type enzymes, kinetic parameters were reported for five enzymes, IMP-1 (8, 11, 13, 14, 22, 24), IMP-2 (17), IMP-3 (8), IMP-4 (3), and IMP-6 (24). Carbapenems and cephems are good substrates for these enzymes, and penicillin-hydrolyzing activities were obviously low in IMP-3 and IMP-6 compared to the other enzymes. The number of amino acid substitutions in IMP-2, IMP-4, IMP-3, and IMP-6 compared to those in IMP-1 were 36, 10, 2, and 1, respectively. Variant β-lactamases, such as IMP-3 and IMP-6, were detectable by estimating the relative activities of enzymes obtained from PCR-positive strains, by hydrolyzing the substrates cephaloridine, benzylpenicillin, and imipenem.

We examined β-lactamase activities by the UV spectrophotometric method (22) using crude cell extracts from PCR-positive strains of 44 Pseudomonas aeruginosa and 2 Alcaligenes xylosoxidans isolates, which were collected in Gunma University Hospital, Maebashi, Japan, over the past 7 years with no duplication among the patients. Among these, we found one A. xylosoxidans strain, isolated in March 2000 from a urine specimen, and two P. aeruginosa strains, isolated in February 1997 from a stool specimen and in August 1998 from a urine specimen, whose benzylpenicillin-hydrolyzing activity was scarcely detectable.

None of the imipenem-resistant genes was transferred by conjugation from these three strains to a P. aeruginosa recipient, ML5017, as seen in the gene blaIMP-1 reported previously (22). Plasmid DNA was prepared from each of the strains by the alkaline-sodium dodecyl sulfate method and analyzed by agarose gel electrophoresis using size marker plasmids of 8.7 (RSF1010), 35 (pSa), 56 (RP4), and 105 (R100-1) kb (1). Plasmid DNAs of different sizes were revealed from each strain: a ca. 56-kb plasmid from P. aeruginosa strain PAI134, ca. 135- and ca. 6.6-kb plasmids from P. aeruginosa strain PAI97, and a ca. 27-kb plasmid from A. xylosoxidans strain AXI2. Southern hybridization was carried out with these DNA preparations using the PCR-amplified 587-bp segment of blaIMP-1 as the probe, which was labeled with digoxigenin-11-dUTP. Hybridization was positive with the plasmid DNA of PAI134 but negative with the plasmid DNAs of PAI97 and AXI2, for which a trace of chromosomal DNA contained in the preparation was hybridized instead (data not shown).

The PAI134 plasmid was introduced by transformation into a laboratory strain of P. aeruginosa ML5017 by selection with 8-μg/ml ceftazidime. The 56-kb plasmid, named pMS455, was isolated from the transformant and digested with the restriction enzyme BamHI. Next, the 4.5-kb BamHI segment was cloned in an Escherichia coli strain, K-12 JM83, using the multicopy vector plasmid pHSG399 (21), constructing the recombinant plasmid pMS600. The nucleotide sequence of a ca. 1,100-bp region including the predicted blaIMP-1 gene was determined by the PCR product direct sequencing method with an ABI377 autosequencer. The gene from PAI134 was identical in sequence to blaIMP-1, but with one base replacement of G by T at nucleotide 145, which led to an amino acid alteration of Val49 to Phe. Subsequently, we subcloned the 4.5-kb BamHI segment into a shuttle vector, pMS360 (9), and introduced the resultant plasmid, pMS364, by transformation into each of the following: P. aeruginosa strain PAO4141 (a β-lactamase-deficient mutant of the PAO line) and E. coli strain K-12 χ1037 (9).

The MICs of various β-lactam antibiotics for pMS455- or pMS364-possessing strains are shown in Table 1. These plasmids conferred resistance to cephems (cefotaxime and ceftazidime) and carbapenems (imipenem and meropenem) on both the E. coli K-12 and P. aeruginosa hosts. The increased MIC levels of the penicillins (ampicillin, piperacillin, and ticarcillin) mediated by pMS455 and pMS364 were relatively low, especially in the E. coli host. The MICs of ticarcillin were not affected by the inhibitor clavulanic acid, and no increase in MICs of aztreonam was observed in pMS455- or pMS364-bearing strains.

TABLE 1.

Resistance levels conferred by IMP-10 metallo-β-lactamasea

Strain and plasmid MIC (μg/ml)
CTX CAZ AMP TIC TIM PIP ATM IPM MEM
P. aeruginosa
    PAI134 >128 >128 >128 128 128 4 4 >128 >128
    PAO4141, pMS455 >128 >128 128 64 64 4 2 8 64
    PAO4141, pMS364 >128 >128 >128 128 128 4 2 32 128
    PAO4141, pMS360 4 0.5 16 8 8 1 1 <0.5 0.5
    PAO4141 4 0.5 16 8 8 1 1 <0.5 0.5
E. coli
    K-12 χ1037, pMS364 64 128 16 32 32 1 <0.5 1 8
    K-12 χ1037, pMS360 <0.5 <0.5 8 2 2 1 <0.5 <0.5 <0.5
    K-12 χ1037 <0.5 <0.5 4 2 2 1 <0.5 <0.5 <0.5
a

pMS455, plasmid-bearing blaIMP-10 gene; pMS364, recombinant plasmid-bearing blaIMP-10 gene; pMS360, vector plasmid. Abbreviations: CTX, cefotaxime; CAZ, ceftazidime; AMP, ampicillin; TIC, ticarcillin; TIM, ticarcillin-clavulanic acid; PIP, piperacilin; ATM, aztreonam; IPM, imipenem; MEM, meropenem.

The blaIMP-1-like genes from the other two strains, P. aeruginosa PAI97 and A. xylosoxidans AXI2, were sequenced by the PCR product direct sequencing method using primers constructed from the conserved sequences of the integron structure, which is known in most cases to flank the blaIMP-1 gene (12). Their nucleotide sequences were identical to that of the PAI134 strain, having a single base replacement of G by T at position 145 of the blaIMP-1 gene. The gene identified in the three different strains and the enzyme it encodes were designated blaIMP-10 and IMP-10 β-lactamase, respectively.

We replaced the HpaI segment consisting of nucleotides from position 127 to 415 of the blaIMP-1 gene in a previously constructed recombinant plasmid, pMS501 (8), with that of the blaIMP-10 gene of pMS600 and named the resultant plasmid pMS601. Accordingly, pMS601 had blaIMP-10 instead of blaIMP-1 in the same background plasmid.

β-Lactamase IMP-10 was prepared from the pMS601-bearing E. coli K-12 JM83 strain, purified to a 305-fold purity with a yield of 36.8% (specific activity, 301 U/mg of protein for 100 μM cephalothin) according to the method described previously (8). The kinetic parameters were determined with the highly purified enzyme. Statistical data were obtained by online analysis (UV absorption method and Lineweaver-Burk plot analysis with the computer system) by measuring the rate of hydrolysis (kcat) and Km values more than three times. When Km values were too large for this system, they were obtained from Michaelis-Menten graphs by measuring the initial hydrolysis rates. The kinetic parameters were compared with those of IMP-1 from the pMS501-bearing strain (Table 2). The kinetic parameters with IMP-1 so far reported were not necessarily in good agreement each other (8, 11, 13, 14, 22, 24). Our data were almost comparable to those of Laraki et al. (11) with the exception for cephalothin and cefotaxime, which had values that were rather close to that described by Marumo et al. (13) or Watanabe et al. (22).

TABLE 2.

Kinetic parameters for hydrolysis of various β-lactam antibiotics by IMP-10 and IMP-1 metallo-β-lactamases

Antibiotic Kinetic parameter for β-lactamase (source)
IMP-10 (pMS601)
IMP-1 (pMS501)
kcat (s−1) Km (μM) kcat/Km (μM−1 s−1) kcat (s−1) Km (μM) kcat/Km (μM−1 s−1)
Cephaloridine 140 ± 18 28 ± 0.8 5.0 62 ± 3.0 7 ± 0.4 8.9
Cephalothin 230 ± 7 4.9 ± 0.3 47 65 ± 2.9 2 ± 0.1 32.5
Cefotaxime 74 ± 6 5.7 ± 0.3 13 23 ± 1.9 1.4 ± 0.1 16
Ceftazidime 51 ± 4 51 ± 4.5 1.0 16 ± 0.9 46 ± 1 0.3
Benzylpenicillin NDa ND 0.07 460 ± 17 240 ± 10 1.9
Ampicillin ND ND 0.06 160 ± 15 140 ± 9 1.1
Carbenicillin ND ND 0.18 15 ± 2 390 ± 12 0.04
Piperacillim ND ND 0.04 200 ± 9 280 ± 10 0.7
Imipenem 220 ± 11 60 ± 3 3.7 130 ± 11 30 ± 3.9 4.3
Meropenem 64 ± 2 47 ± 1.5 1.4 13 ± 0.5 7 ± 1.2 1.9
a

ND, not determined.

The hydrolyzing activities of IMP-10 for penicillins except for carbenicillin were very low compared to those of IMP-1, indicating that a single amino acid alteration resulting from a single point mutation caused a decrease in penicillin-hydrolyzing ability in this variant IMP-10 metallo-β-lactamase. The position of the altered amino acid corresponded to 31 in the mature enzyme (15). As previously reported, a single amino acid substitution of Ser196 (IMP-1 β-lactamase) for Gly196 (IMP-3 and IMP-6 β-lactamases) resulted in a markedly low level of penicillin-hydrolyzing activity and more efficient hydrolysis of meropenem than imipenem (24). In contrast, the substitution of Phe for Val at position 31 had little effect on the kinetic parameters for both imipenem and meropenem, as well as the cephalosporins (cephaloridine, cephalothin, cefotaxime, and ceftazidime). As the crystal structure of IMP-1 revealed that amino acid residues 22 to 31 constituted a flexible loop structure called a flap, which affected the affinity of the enzyme to substrates (4), it was predicted that the replacement of residue 31, which was positioned at the root of the flap, affected the substrate specificity especially for penicillins by altering the three-dimensional structure of the enzyme protein.

We used the PCR method with specific primers to identify the integron structure (18) and revealed that the gene blaIMP-10 in three different strains was located in class 1 integrons (5). In all cases, the blaIMP-10-containing cassette that was inserted into the specific target, GTTRRRY, on the integrons was identical in its nucleotide sequence (GenBank accession numbers AB074433 to -35) to that of the blaIMP-1-containing cassette (10, 16). This finding suggested that blaIMP-10 as well as blaIMP-1 were movable among replicons in different strains, causing disseminations of different species of bacteria producing IMP-type class B β-lactamases, especially in Japan (7, 19, 20).

Acknowledgments

We thank Y. Yamaguchi, Chiba University, and S. Murayama, Teikyo University School of Medicine, for technical assistance.

REFERENCES

  • 1.Bukhari, A. I., J. A. Shapiro, and S. L. Adhya (ed.). 1977. Bacterial plasmids, p. 601-704. In DNA insertion elements, plasmids, and episomes. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • 2.Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chu, Y.-M., M. Afzal-Shah, E. T. S. Houang, M.-F. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 45:710-714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Concha, N. O., C. A. Janson, P. Rowling, S. Person, C. A. Cheever, B. P. Clarke, C. Lewis, M. Galleni, J.-M. Frere, D. J. Payne, J. H. Bateson, and S. S. Abdel-Meguid. 2000. Crystal structure of the IMP-1 metallo-β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxyl inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39:4288-4298. [DOI] [PubMed] [Google Scholar]
  • 5.Hall, R. M., and C. M. Collis. 1995. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol. Microbiol. 15:593-600. [DOI] [PubMed] [Google Scholar]
  • 6.Hawkey, P. M., J. Xiong, H. Ye, H. Li, F. H. M'Zali. 2001. Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol. Lett. 194:53-57. [DOI] [PubMed] [Google Scholar]
  • 7.Hirakata, Y., K. Izukikawa, T. Yamaguchi, H. Takemura, H. Tanaka, R. Yoshida, J. Matsuda, M. Nakano, K. Tomono, S. Maesaki, M. Kakau, Y. Yamada, S. Kamihira, and S. Kohno. 1998. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-β-lactamase gene blaIMP. Antimicrob. Agents Chemother. 42:2006-2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Iyobe, S., H. Kusadokoro, J. Ozaki, N. Matsumura, S. Minami, S. Haruta, T. Sawai, and K. O'Hara. 2000. Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase. Antimicrob. Agents Chemother. 44:2023-2027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Iyobe, S., M. Tsunoda, and S. Mitsuhashi. 1994. Cloning and expression in Enterobacteriaceae of the extended-spectrum β-lactamase gene from a Pseudomonas aeruginosa plasmid. FEMS Microbiol. Lett. 121:175-180. [DOI] [PubMed] [Google Scholar]
  • 10.Iyobe, S., H. Yamada, and S. Minami. 1996. Insertion of a carbapenemase gene cassette into an integron of a Pseudomonas aeruginosa plasmid. J. Antimicrob. Chemother. 38:1114-1115. [DOI] [PubMed] [Google Scholar]
  • 11.Laraki, N., N. Franceschini, G. M. Rossolini, P. Santucci, C. Meunier, E. de Pauw, G. Amicosante, J. M. Frere, and M. Galleni. 1999. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob. Agents Chemother 43:902-906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Marumo, K., A. Takeda, Y. Nakamura, and K. Nakaya. 1995. Purification and characterization of metallo-β-lactamase from Serratia marcescens. Microbiol. Immunol. 39:27-33. [DOI] [PubMed] [Google Scholar]
  • 14.Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing β-lactamases. Antimicrob. Agents Chemother. 41:223-232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Recchia, G. D., and R. M. Hall. 1995. Gene cassettes: a new class of mobile element. Microbiology 141:3015-3027. [DOI] [PubMed] [Google Scholar]
  • 17.Riccio, M. L., N. Franceschini, L. Boschi, B. Caravelli, G. Cornaglia, R. Fontana, G. Amicosante, and G. M. Rossilini. 2000. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44:1229-1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rosser, S. J., and H.-K. Young. 1999. Identification and characterization of class 1 integrons in bacteria from an aquatic environment. J. Antimicrob. Chemother. 44:11-18. [DOI] [PubMed] [Google Scholar]
  • 19.Senda, K., Y. Arakawa, S. Ichiyama., K. Nakashima, H. Ito, S. Ohsuka, K. Shimokata, N. Kato, and M. Ohta. 1996. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol. 34:2909-2913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Takahashi, A., S. Yomoda, I. Kobayashi, T. Okubo, M. Tsunoda, and S. Iyobe. 2000. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J. Clin. Microbiol. 38:526-529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Takeshita, S., M. Sato, M. Oba, W. Masahashi, and T. Hashimoto-Gotoh. 1987. High-copy-number and low-copy-number plasmid vectors for lacZ α-complementation and chloramphenicol- or kanamycin-resistance selection. Gene 61:63-74. [DOI] [PubMed] [Google Scholar]
  • 22.Watanabe, M., S. Iyobe, M. Inoue, and S. Mitsuhashi. 1991. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35:147-151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Yan, J.-J., W.-C. Ko, and J.-J. Wu. 2001. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-β-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:2368-2371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yano, H., A. Kuga, R. Okamoto, H. Kitasato, T. Kobayashi, and M. Inoue. 2001. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob. Agents Chemother. 45:1343-1348. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES